NCT02155530View on ClinicalTrials.gov

COmparison and Modification in Neointimal Pattern Assessed by Optical Coherence Tomography With High Versus Moderate Efficacy Statin Treatment After Drug Eluting Stent Implantation: COMPASS Trial

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

June 30, 2016

Conditions
Coronary Artery Disease
Interventions
DRUG

Atorvastatin 40mg

homogenous neointimal pattern at baseline OCT and randomized to atorvastatin 40 mg group

DRUG

pravastatin 20 mg

Intervention description : homogenous neointimal pattern at baseline OCT and randomized to pravastatin 20 mg group

Trial Locations (1)

120-752

Severance Hospital, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT02155530 - COmparison and Modification in Neointimal Pattern Assessed by Optical Coherence Tomography With High Versus Moderate Efficacy Statin Treatment After Drug Eluting Stent Implantation: COMPASS Trial | Biotech Hunter | Biotech Hunter